Quantcast
Channel: BioTuesdays » non-dilutive capital
Browsing latest articles
Browse All 2 View Live

Image may be NSFW.
Clik here to view.

Hydra Biosciences to have Phase 1 TRPA1 data soon

Closely-held Hydra Biosciences expects to complete Phase 1 trials of its HX-100 inhibitor of the Transient Receptor Potential (TRPA1) ion channel as a treatment for painful diabetic neuropathy and...

View Article



Image may be NSFW.
Clik here to view.

Cellectar gets NCI grant for PDC platform

Cellectar Biosciences (NASDAQ:CLRB) has received initial notice of award for a Phase I-II Fast-Track Small Business Innovation Research (SBIR) grant. The SBIR grant provides up to $2.3-million over 2...

View Article
Browsing latest articles
Browse All 2 View Live




Latest Images